Skip to main content
Journal of the Egyptian National Cancer Institute

Table 3 Effect of melatonin to biomarker concentration and tumor residue percentage

From: Effect of melatonin supplementation in combination with neoadjuvant chemotherapy to miR-210 and CD44 expression and clinical response improvement in locally advanced oral squamous cell carcinoma: a randomized controlled trial

Variable

Melatonin (n = 13)

%Tumor residue

p

miRNA-210

 Decreased

13

82.74 (37.5)

–

 Increased

0

–

 

CD 44

 Decreased

11

84.22

0.114

 Increased

2

115.06

Back to article page